Sort
21,281 grants matching “influenza”
Distinct Function and Control of Regulatory T Cell Subsets During Influenza
$199,840Jason W. Griffith · Massachusetts General Hospital · K08 · FY2021 · AI
Distinct Function and Control of Regulatory T Cell Subsets During Influenza
$199,840Jason W. Griffith · Massachusetts General Hospital · K08 · FY2018 · AI
Distinct Function and Control of Regulatory T Cell Subsets During Influenza
$199,840Jason W. Griffith · Massachusetts General Hospital · K08 · FY2017 · AI
Influenza host specific glycan motif identification through systems biology
$199,831Xiufeng Henry Wan · University Of Missouri-Columbia · R21 · FY2021 · AI
AIP inhibition of IRF7 and innate antiviral signaling
$199,810Edward W Harhaj · Pennsylvania State Univ Hershey Med Ctr · R21 · FY2022 · AI
HIV Infection, Placental Inflammation, and Early Childhood Outcomes in HIV-exposed, Uninfected Infants in Uganda
$199,800Lisa M Bebell · Massachusetts General Hospital · K23 · FY2022 · AI
Novel Hybrid Computational Models to Disentangle Complex Immune Responses
$199,789Esteban Abelardo Hernandez Vargas · University Of Idaho · R01 · FY2025 · GM
EVALUATING USE A RAPID TESTING FOR INFLUENZA IN OUTPATIENT MEDICA SETTING
$199,781Nancy Jean Kupka · Joint Commission · U47 · FY2008 · CI
Treatment of bacterial pneumonia after influenza
$199,763Jonathan A McCullers · St. Jude Children'S Research Hospital · R21 · FY2010 · AI
Core C: Immune Assay
$199,725Boris Michael Hartmann · Icahn School Of Medicine At Mount Sinai · U19 · FY2019 · AI
RAPID: Modeling the Severity and Transmissibility of COVID-19 in the USA with Intrinsic Behavior Change
$199,580Pete Riley · Predictive Science Incorporated · · FY2020 · BIO
Data Management and Resources Dissemination Core
$199,536Sumit K Chanda · Icahn School Of Medicine At Mount Sinai · U19 · FY2014 · AI
Immunological Reagent Resource
$199,533Vijay K Kuchroo · Yale University · U19 · FY2014 · AI
Quantitative Gene Expression Core
$199,533Keith Moore · Yale University · U19 · FY2014 · AI
The Affordable Care Act: MCV/PCV & Pertussis
$199,515Tracey L. Weeks · Connecticut State Dept Of Public Health · U01 · FY2011 · CI
Mechanisms of non-neutralizing antibody-mediated protection from influenza virus
$199,430Denise A Kaminski · University Of Rochester · R21 · FY2008 · AI
Protein-protein interaction essential for bacterial growth and virulence
$199,390Mark A Saper · University Of Michigan At Ann Arbor · R21 · FY2013 · AI
Safe mucosal vaccines
$199,375Terry D. Connell · State University Of New York At Buffalo · R21 · FY2015 · DE
Individual and Neighborhood Vulnerability to the Spanish Flu
$199,375John R Logan · Brown University · R21 · FY2024 · HD
Malaria Genomic Epidemiology for Identifying Sources of Malaria Infection and Transmission
$199,375Sarah Kay Volkman · Harvard School Of Public Health · R21 · FY2020 · AI
Vaccine Induced Activation of T Follicular Helper Cell Subsets
$199,241Hideki Ueno · Baylor Research Institute · U19 · FY2012 · AI
Naturally occurring human antibodies to alphavirus infection
$199,239Christopher F Basler · Icahn School Of Medicine At Mount Sinai · R21 · FY2014 · AI
Participation of Mucosal Type I Interferon Signaling in Pulmonary Disease
$199,238Alice S Prince · Columbia University Health Sciences · R21 · FY2010 · AI
Identification and Hit-to-Lead Development of Influenza A Virus Inhibitors
$199,226Richard K. Plemper · Georgia State University · R21 · FY2016 · AI
Collaborative cross mice as a new model for diverse human outcomes of St. Louis encephalitis virus disease
$199,187Lark L Coffey · University Of California At Davis · R21 · FY2024 · AI